---
title: "eXoZymes wins USD 2.03 million NIH grant for cannabinoid analog development"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290947188.md"
description: "Exozymes Inc. has secured a $2.03 million NIH NIGMS Phase IIB SBIR grant to advance the development of rare cannabinoids and engineered cannabinoid analogs for drug discovery. The project, starting July 1, 2026, focuses on scaling enzyme systems and conducting preclinical receptor-binding assays. Occidental College will receive a sub-award under this program."
datetime: "2026-06-26T10:03:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290947188.md)
  - [en](https://longbridge.com/en/news/290947188.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290947188.md)
generator: "portal-rs"
---

# eXoZymes wins USD 2.03 million NIH grant for cannabinoid analog development

-   Exozymes secured a $2.03 million NIH NIGMS Phase IIB SBIR grant to advance rare cannabinoids and engineered cannabinoid analogs for drug discovery. \* Work is slated to start July 1, 2026, targeting scale-up of enzyme systems and preclinical receptor-binding assays for its cannabinoid library. \* Occidental College, via Vikram Shende’s lab, will receive a sub-award under the program. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-030205), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [EXOZ.US](https://longbridge.com/en/quote/EXOZ.US.md)

## Related News & Research

- [EXOZ: NCT program exceeded targets; $6M raised and $2M NIH grant secured for R&D and commercialization](https://longbridge.com/en/news/296532185.md)
- [Exozymes wins NIH grant worth $2.03 million for cannabinoid analog development](https://longbridge.com/en/news/290734082.md)
- [25 rare and beautiful coins that are worth millions](https://longbridge.com/en/news/295960689.md)
- [Bugatti Showcases Steve Dimopoulos' One-of-One Chiron at Pebble Beach Automotive Week](https://longbridge.com/en/news/296665074.md)
- [16:47 ETMr. Muscle Car Engels Gualdani Educates on Private Sales Transactions Between Collectors Via Expert Website from HelloNation](https://longbridge.com/en/news/296534869.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**